MP16-20 FINAL RESULTS OF A PHASE I, SINGLE-ARM CLINICAL TRIAL OF THE COMBINATION OF DURVALUMAB AND VICINEUM IN BCG UNRESPONSIVE, HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER PATIENTS (NCT03258593).

Autor:	Rivera-Marquez, Genesis, Walter, Beatriz, Dolan, Rebecca, Belfield, Sonia, Merino, Maria, Gurram, Sandeep, Apolo, Andrea, Niglio, Scot, Agarwal, Piyush, Valera, Vladimir A.
Předmět:	NON-muscle invasive bladder cancer BLADDER cancer BCG immunotherapy CANCER patients CLINICAL trials
Zdroj:	Journal of Urology; 2024 Supplement 5, Vol. 211, pe248-e248, 1p
Databáze:	Supplemental Index
Externí odkaz:	Zobrazit plný text záznamu